SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the Sensitivity and Specificity of
SonoVue®-enhanced ultrasound is superior to that of unenhanced ultrasound for the
characterization of benign versus malignant FLLs using final diagnosis based on histology or
combined imaging (CE-CT and/or CE MRI)/clinical data as truth standard.